(3-Carboxypropyl)triphenylphosphonium bromide

• Catalog No.: 349720
• CAS Number: 17857-14-6
• M. F.: C22H22BrO2P
• M. W.: 429.286641
• Purity: 98%

SYNONYMS

• Title: (3-羧丙基)三苯基溴化膦
• IUPAC name: (3-carboxypropyl)triphenylphosphanium bromide
• IUPAC Traditional name: (3-carboxypropyl)triphenylphosphanium bromide
• Synonyms: (4-Hydroxy-4-oxobutyl)triphenylphosphonium bromide

DATABASE IDS

• CAS Number: 17857-14-6
• MDL Number: MFCD00274196
• PubChem SID: 24861704

PROPERTIES

• Linear Formula: HO2C(CH2)3P(C6H5)3Br
• Purity: 98%
• Melting Point: 244-247 °C(lit.)
• GHS Signal Word: Warning
• GHS Hazard statements: H315-H319-H335
• European Hazard Symbols: Irritant (Xi)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• GHS Precautionary statements: P261-P305 + P351 + P338
• Risk Statements: 36/37/38
• Safety Statements: 26-36
• German water hazard class: 3

DETAILS

Description (English)

Packaging
25, 100 g in glass bottle
Application
Reactant for preparation of:
• Piperamide analogs as histone deacetylase (HDAC) inhibitors with antitumor activity1
• Boron-containing benzoxaboroles as antimalarial agents2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Solandelactone E via Sharpless epoxidation, Taber cyclopropanation, chemoselective reductions and lithiation-borylation-allylation sequence4
• Organotin compounds as antifungal agents5
• Oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B for negative regulation of insulin pathway (a promising target for treatment of diabetes and obesity)6
• 11-oxa prostaglandin analogs with ocular hypotensive activity7

Description (简体中文)

包装
25, 100 g in glass bottle
Application
Reactant for preparation of:
• Piperamide analogs as histone deacetylase (HDAC) inhibitors with antitumor activity1
• Boron-containing benzoxaboroles as antimalarial agents2
• Methyl alkenyl quinolones as antimycobacterial agents3
• Solandelactone E via Sharpless epoxidation, Taber cyclopropanation, chemoselective reductions and lithiation-borylation-allylation sequence4
• Organotin compounds as antifungal agents5
• Oleanolic acid derivatives as inhibitors of protein tyrosine phosphatase 1B for negative regulation of insulin pathway (a promising target for treatment of diabetes and obesity)6
• 11-oxa prostaglandin analogs with ocular hypotensive activity7